Literature DB >> 8163645

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

B J van Vlijmen1, A M van den Maagdenberg, M J Gijbels, H van der Boom, H HogenEsch, R R Frants, M H Hofker, L M Havekes.   

Abstract

Apolipoprotein E3-Leiden (APOE*3-Leiden) transgenic mice have been used to study the effect of different cholesterol-containing diets on the remnant lipoprotein levels and composition and on the possible concurrent development of atherosclerotic plaques. On high fat/cholesterol (HFC) diet, the high expressing lines 2 and 181 developed severe hypercholesterolemia (up to 40 and 60 mmol/liter, respectively), whereas triglyceride levels remained almost normal when compared with regular mouse diet. The addition of cholate increased the hypercholesterolemic effect of this diet. In lines 2 and 181, serum levels of apo E3-Leiden also increased dramatically upon cholesterol feeding (up to 107 and 300 mg/dl, respectively). In these high expressing APOE*3-Leiden transgenic mice, the increase in both serum cholesterol and apo E3-Leiden occurred mainly in the VLDL/LDL-sized fractions, whereas a considerable increase in large, apo E-rich HDL particles also occurred. In contrast to the high expressing lines, the low expressing line 195 reacted only mildly upon HFC diet. On HFC diets, the high expresser APOE*3-Leiden mice developed atherosclerotic lesions in the aortic arch, the descending aorta, and the carotid arteries, varying from fatty streaks containing foam cells to severe atherosclerotic plaques containing cholesterol crystals, fibrosis, and necrotic calcified tissue. Quantitative evaluation revealed that the atherogenesis is positively correlated with the serum level of cholesterol-rich VLDL/LDL particles. In conclusion, with APOE*3-Leiden transgenic mice, factors can be studied that influence the metabolism of remnant VLDL and the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163645      PMCID: PMC294153          DOI: 10.1172/JCI117117

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Carbohydrate diet-induced changes in very low density lipoprotein composition and structure.

Authors:  J L Witztum; G Schonfeld
Journal:  Diabetes       Date:  1978-12       Impact factor: 9.461

2.  Genetic factors controlling structure and expression of apolipoproteins B and E in mice.

Authors:  A J Lusis; B A Taylor; D Quon; S Zollman; R C LeBoeuf
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

3.  Cholesterol determination in high-density lipoproteins separated by three different methods.

Authors:  M F Lopes-Virella; P Stone; S Ellis; J A Colwell
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

Review 4.  The pathogenesis of atherosclerosis: atherogenesis and inflammation.

Authors:  J M Munro; R S Cotran
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

5.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162

6.  Variation in susceptibility to atherosclerosis among inbred strains of mice.

Authors:  B Paigen; A Morrow; C Brandon; D Mitchell; P Holmes
Journal:  Atherosclerosis       Date:  1985-10       Impact factor: 5.162

Review 7.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

8.  Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H.

Authors:  B Paigen; P A Holmes; D Mitchell; D Albee
Journal:  Atherosclerosis       Date:  1987-04       Impact factor: 5.162

9.  Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins.

Authors:  R C LeBoeuf; D L Puppione; V N Schumaker; A J Lusis
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

10.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Authors:  R J Havel; Y Chao; E E Windler; L Kotite; L S Guo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

View more
  59 in total

1.  The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.

Authors:  M Kliffen; E Lutgens; M J Daemen; E D de Muinck; C M Mooy; P T de Jong
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice.

Authors:  Bernard M van den Berg; Jos A E Spaan; Hans Vink
Journal:  Pflugers Arch       Date:  2008-10-07       Impact factor: 3.657

3.  Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.

Authors:  Elizabeth D Crane; Ali A Al-Hashimi; Jack Chen; Edward G Lynn; Kevin Doyoon Won; Šárka Lhoták; Magda Naeim; Khrystyna Platko; Paul Lebeau; Jae Hyun Byun; Bobby Shayegan; Joan C Krepinsky; Katey J Rayner; Serena Marchiò; Renata Pasqualini; Wadih Arap; Richard C Austin
Journal:  JCI Insight       Date:  2018-12-20

4.  Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion.

Authors:  Kanami Sugimoto-Kawabata; Hiroshi Shimada; Kaoru Sakai; Kazuo Suzuki; Thomas Kelder; Elsbet J Pieterman; Louis H Cohen; Louis M Havekes; Hans M Princen; Anita M van den Hoek
Journal:  J Lipid Res       Date:  2013-02-22       Impact factor: 5.922

5.  Evaluation of antiatherosclerotic drugs by Raman spectroscopy.

Authors:  S W F van de Poll; A van der Laarse
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

Review 6.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

7.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties.

Authors:  Jurgen W G E VanTeeffelen; Alina A Constantinescu; Judith Brands; Jos A E Spaan; Hans Vink
Journal:  J Physiol       Date:  2008-05-01       Impact factor: 5.182

9.  Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.

Authors:  Shannon M Bailey; Sudheer K Mantena; Telisha Millender-Swain; Yavuz Cakir; Nirag C Jhala; David Chhieng; Kent E Pinkerton; Scott W Ballinger
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

10.  Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.

Authors:  Marijana Radonjic; Jorn R de Haan; Marjan J van Erk; Ko Willems van Dijk; Sjoerd A A van den Berg; Philip J de Groot; Michael Müller; Ben van Ommen
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.